Key Market Indicators
Poland's insulin export market is projected to decline slightly over the next five years, with values expected to drop from approximately $15.4 million in 2023 to around $14.9 million by 2028. This represents an average annual decrease of 0.7%. Despite this recent downturn, Poland has seen a historical growth in its insulin supply, which has increased by an average of 2.5% annually since 1999. In the global rankings for 2023, Poland occupied the 16th spot, while Ukraine surged ahead with $15.4 million in exports. France, Italy, and China secured the second, third, and fourth positions, respectively. On the import front, Poland's insulin market is also expected to see a slight decline. By 2028, imports are forecasted to reach roughly $128.3 million, down from $131.9 million in 2023. This indicates an average yearly decrease of 0.6%. Since 1999, the country's demand for imported insulin has decreased by an average of 1.6% per year.
